Tag: Sarepta

Needham & Corporate LLC Trims Sarepta Therapeutics (NASDAQ:SRPT) Goal Value to $82.00

[ad_1] Sarepta Therapeutics (NASDAQ:SRPT – Get Unfastened Record) had its value goal decreased via analysis analysts at Needham & Corporate LLC from $185.00 to $82.00 in a record launched on Tuesday, Benzinga reviews. The company these days has a “purchase” ranking at the biotechnology corporate’s inventory. Needham & Corporate LLC’s value function would point out […]

Back To Top